Furthermore, COVID-19-associated coagulopathy, characterized by elevated D-dimer levels, prolonged prothrombin time (PT), and increased risk of thrombotic events, underscores the importance of assessing coagulation profiles and thromboembolic risk in affected individuals [13]. The gene discussed is F2; the disease is blood coagulation disease.